A digital revolution  A person-centric approach

GSK, Stevenage
26 November 2024

Advanced Therapies Integrates Leadership Team and Advisory Board

The Executive Advisory Board is ideally placed to provide expert insight into the critical issues and challenges facing the Advanced Therapies industry today. Together they bring a wealth of first-hand experience and knowledge, sharing our determination to encourage further collaboration amongst key stakeholders shaping the future of the Advanced Therapies and ATMP industry.

We have assembled a group of renowned experts from across the sector. Kindly contact Christopher Watt or Samuel Thangiah if you would like to be considered for the Advanced Therapies Advisory Board.

Samuel Thangiah

SHARON BROWNLOW
(Chair)

Chief Business Officer

Cell and Gene Therapy Catapult

ANDREW FARQUHARSON

 Executive Director

LifeArc

SALLY ANN FORSYTH OBE

Chief Executive Officer

Stevenage Bioscience Catalyst

JESÚS ZURDO

Global Head Cell, Gene Therapy & Bioproduction

Horizon Discovery

MARTINO PICARDO

Chairman

Discovery Park

BRIAN MULLAN

Head of Innovation, Analytical and Process Development – Cell and Gene Therapies

Yposkesi

SVEN KILI

Chief Executive Officer

Antion Biosciences

JASON FOSTER

Chief Executive Officer and Executive Director

Ori Biotech

FRANCESCA GLIUBICH

Director

London Advanced Therapies

STUART FORBES

Professor of Transplantation and Regenerative Medicine

University of Edinburgh

A digital revolution  A person-centric approach

GSK, Stevenage
26 November 2024